Astrazeneca COVID-19 vaccine effective against Delta, Kappa variants
The study by Oxford university investigated the ability of monoclonal antibodies in Sera from recovered people and from vaccinated people to neutralize the Delta and Kappa variantsWorking with AstraZeneca, SII, Indian govt to restart Covid-19 vaccine shipments: WHO Official
WHO expects SII volumes to open up again in the fourth quarter for COVAX
AstraZeneca vaccine's chief investigator endorses India's 12-16 week Covishield dose gap
Professor Andrew Pollard noted that in India, the vast majority of the population is unvaccinated and, therefore, unprotected at a time when the Delta variant is a widespread and increasing threat
AstraZeneca covid-19 antibody treatment suffers setback
Drug's efficacy as post-infection therapy falls short in clinical trial, but potential preventative use is still undergoing testing
Italy suspends use of AstraZeneca vaccine for people under 60 year old
Italy on Friday suspended the use of the AstraZeneca vaccine for people under 60 years old, health officials announced at a weekly press conference on the Covid-19 pandemic
AstraZeneca Pharma India Ltd - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith Certificate dated June 4, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
Astra Covid vaccine linked with small risk of low blood platelets: Study
The Oxford-AstraZeneca vaccine is known in India as Covishield Thailand debuts locally made AstraZeneca but supplies are tight
The government has said it will produce 6 million doses in June, then 10 million doses each month from July to November, and 5 million doses in December.
Centre yet to decide on offering legal protection to domestic COVID-19 vaccines manufacturers
India has been inoculating people with the AstraZeneca vaccine produced locally by the Serum Institute of India (SII) and Covaxin made by local firm Bharat BiotechUS removes DPA ratings on AstraZeneca, Novavax, Sanofi vaccines
US companies can now take their own decision on whom they want to sell their vaccines